Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007/s00406-015-0600-6
- Subjects: DOENÇA DE ALZHEIMER; FÁRMACOS (SISTEMA NERVOSO CENTRAL); PROTEÍNAS QUINASES; FOSFOLIPASES A
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Archives of Psychiatry and Clinical Neuroscience
- Volume/Número/Paginação/Ano: v. 265, n. 8, p. 701-706, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TALIB, L. L. et al. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 8, p. 701-706, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00406-015-0600-6. Acesso em: 29 maio 2024. -
APA
Talib, L. L., Hototian, S. R., Joaquim, H. P. G., Forlenza, O. V., & Gattaz, W. F. (2015). Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, 265( 8), 701-706. doi:10.1007/s00406-015-0600-6 -
NLM
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 maio 29 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6 -
Vancouver
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 maio 29 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6 - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
Informações sobre o DOI: 10.1007/s00406-015-0600-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
